➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Dow
McKinsey
Johnson and Johnson
Express Scripts

Last Updated: October 22, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Chiauranib

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Chiauranib?

Chiauranib is an investigational drug.

There have been 7 clinical trials for Chiauranib. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2019.

The most common disease conditions in clinical trials are Ovarian Neoplasms, Lymphoma, Non-Hodgkin, and Lymphoma. The leading clinical trial sponsors are Chipscreen Biosciences, Ltd. and [disabled in preview].

There is one US patent protecting this investigational drug.

Recent Clinical Trials for Chiauranib
TitleSponsorPhase
Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's LymphomaChipscreen Biosciences, Ltd.Phase 1/Phase 2
Chidamide in Combination With Chemotherapy in Patients With Ovarian CancerChipscreen Biosciences, Ltd.Phase 2
Study of Chiauranib in Patients With Advanced Hepatocellular CarcinomaChipscreen Biosciences, Ltd.Phase 1

See all Chiauranib clinical trials

Clinical Trial Summary for Chiauranib

Top disease conditions for Chiauranib
Top clinical trial sponsors for Chiauranib

See all Chiauranib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Dow
McKinsey
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.